{
    "2020-05-19": [
        [
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：蒋仁生及其一致行动人合计解除质押5775万股",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "解除质押",
                        "5775万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "谁能当疫情的“救世主”？疫苗的发展黄金期已至",
                "features": {
                    "keywords": [
                        "疫情",
                        "疫苗",
                        "发展黄金期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "渝股点金｜智飞生物：良好业绩加持 续创历史新高",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "良好业绩",
                        "历史新高"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "129股遭高管减持 智飞生物减持金额最多 减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "高管减持",
                        "减持金额最多"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
                "features": {
                    "keywords": [
                        "医药生物",
                        "两会",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "资金汇集白马股，A股千亿市值军团扩至近百家",
                "features": {
                    "keywords": [
                        "白马股",
                        "A股",
                        "千亿市值"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药 | 行业周报】5月报前瞻正在逐步兑现，继续看好“疫情后修复”与“新基建”",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "疫情后修复",
                        "新基建"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫情后修复",
                        "新基建"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}